{
  "ptid_time": "009_S_2381_2013-06-20",
  "img_path": "/data/qiuhui/data/adni/images/009_S_2381/2013-06-20/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 32,743 mm³, 15.0% below the reference mean. With a Z-score of -0.36 (36.0th percentile), this represents normal volume ; hippocampal volume measures 5,616 mm³, 25.7% below the reference mean. With a Z-score of -2.51 (0.6th percentile), this represents significant atrophy; whole brain volume measures 1,160,920 mm³, 7.6% above the reference mean. With a Z-score of 0.98 (83.7th percentile), this represents normal volume ; entorhinal cortex volume measures 3,018 mm³, 26.4% below the reference mean. With a Z-score of -1.79 (3.7th percentile), this represents moderate atrophy; fusiform gyrus volume measures 20,962 mm³, 11.3% above the reference mean. With a Z-score of 0.96 (83.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,343 mm³, 4.7% above the reference mean. With a Z-score of 0.42 (66.4th percentile), this represents normal volume . ",
  "text_data": "Age is 71.1 years. Gender is Male. Education: 16 years. MMSE: 28.0. MoCA: 25.0. Logical Memory: 13.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.53 SUVR (profound elevated); Amyloid beta: 769.10 pg/mL (normal ); Total tau: 635.50 pg/mL (profound elevated); Phosphorylated tau: 65.15 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant hippocampal atrophy (Z-score -2.51, 0.6th percentile) and moderate entorhinal cortex atrophy (Z-score -1.79, 3.7th percentile), both key regions in Alzheimer's pathology. Despite normal Aβ levels, the profound elevations in T-tau, P-tau, and AV45 (amyloid PET) strongly suggest Alzheimer's neurodegeneration. The MMSE (28) and MoCA (25) scores are borderline for MCI but may not yet reflect significant cognitive decline.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease** (biomarker-supported, with neurodegeneration and tau pathology but preserved cognitive function near the normal range).  \n\n**Confidence:** **High** (due to clear biomarker evidence of tauopathy and neurodegeneration in Alzheimer’s-vulnerable regions, despite normal Aβ and near-normal cognition).  \n\n*Note:* The discrepancy between normal Aβ and elevated AV45 (amyloid PET) is unusual—possible lab error in CSF Aβ or a rare amyloid-PET positive, CSF Aβ-normal variant. Rechecking biomarkers may be warranted.",
  "timestamp": "2025-07-25T22:17:38.551629"
}